Galvez, K. 2019. Efficacy of Generic Bortezomib Used as a Part of CyBorD Regimen to Achieve Complete Response in Multiple Myeloma. Innovative Journal of Medical and Health Sciences. 9, 1 (Feb. 2019), 247–251. DOI:https://doi.org/10.15520/ijmhs.v9i1.2431.